People may be at increased risk for developing diabetes for up to a year after a diagnosis of COVID-19, according to two studies. Additionally, organ donation from dying donors with current or previous COVID-19 infection is likely safe, transplant teams from the United States and Italy will report at the April 2022 European Congress of Clinical Microbiology & Infectious Diseases meeting.
Two months after receiving a gene-edited pig heart, David Bennett Sr. passed away at the age of 57 years.
Yvonne Bryson, M.D., an infectious disease researcher at UCLA, presented the case of an American woman who was cured of HIV after receiving a new transplant procedure that leverages donated umbilical cord blood.
A U.S. patient with leukemia has become the first woman and the third person to date to be cured of HIV after receiving a stem cell transplant from a donor who was naturally resistant to the virus that causes AIDS, researchers reported on February 15.
Easier-to-produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in miceClinical Trials, COVID-19 booster shots, COVID-19 shots, COVID-19 Vaccines, Immune System, Immunity, Intranasal vaccines, Low-Income Countries, Lung Transplants, Messenger RNA (mRNA) Vaccines, Mice, Middle-Income Countries, Nasal Sprays, New England Journal of Medicine, R&D, Researchers, Yale University
A COVID-19 vaccine that can be produced locally in low-income and middle-income countries is yielding promising results in early clinical trials, researchers say. Other researchers believe that once the body has been “primed” by mRNA vaccines to recognize and attack the coronavirus, a booster containing purified versions of virus’ spike protein that could be given intranasally would have many advantages.
TScan Therapeutics secured clearance from the U.S. Food and Drug Administration for the company’s investigational new drug application to assess TSC-100 in treating patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation (HCT).
Research Roundup: Nanotherapy and Islet Transplants for Diabetes and MoreBusiness, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Diabetes, DNA, Drug Delivery, Immunosuppressants, Islet cells, Messenger RNA (mRNA) Vaccines, Nature Nanotechnology, Northwestern University, R&D, San Diego (UCSD), San Francisco (UCSF), Transplants, Type 1 Diabetes, Viral Infections
Researchers have been working to develop approaches to curing Type 1 diabetes by transplanting healthy islet cells into the pancreas. Investigators at Northwestern University have developed a technique to make the immunomodulation effect of immunosuppressive drugs more effective.
A U.S. man with terminal heart disease was implanted with a genetically modified pig heart in a first-of-its-kind surgery, and three days later the patient is doing well, his doctors reported on January 10.
Angion Biomedica and Vifor Pharma announced that their Phase III trial on ANG-3777 for renal transplant patients did not meet the study’s primary and secondary endpoints.
Surgeons from NYU Langone Health hit a major milestone in transplantation science after successfully attaching a pig’s kidney to a human patient and watching it work for several hours.